Ballal Rahul D. - Insider Non-Derivative Transactions at Enliven Therapeutics, Inc. (ELVN) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Apr 11, 2024, Ballal Rahul D.'s relationship to Enliven Therapeutics, Inc. (ELVN) is Director, and currently has 75,741 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ELVN insiders.

Data Source: SEC.
Ballal Rahul D. - Insider Non-Derivative Transactions of ELVN Common Stock
Ballal Rahul D. - Insider Non-Derivative Transactions at ELVN
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Apr 12, 2024 Sell -- (Common Stock) 3068 25.21 22341
Apr 12, 2024 Sell -- (Common Stock) 20032 25 25409
Apr 12, 2024 Sell -- (Common Stock) 30300 23.14 45441
Apr 12, 2024 M -- (Common Stock) 48820 12.6 71161
Apr 12, 2024 M -- (Common Stock) 4580 19.68 75741
Apr 11, 2024 Sell -- (Common Stock) 13600 21.01 22341
Apr 11, 2024 M -- (Common Stock) 13600 12.6 35941
Apr 5, 2024 Sell -- (Common Stock) 3485 19.15 22341
Apr 5, 2024 M -- (Common Stock) 3485 12.6 25826
Apr 2, 2024 Sell -- (Common Stock) 3237 19.08 22341
Apr 2, 2024 M -- (Common Stock) 94 12.6 22435
Apr 2, 2024 M -- (Common Stock) 3143 5.52 25578
Mar 21, 2024 Sell -- (Common Stock) 13278 19.16 22341
Mar 21, 2024 M -- (Common Stock) 13278 5.52 35619